Merck and Moderna’s Intismeran Autogene Plus Keytruda Meets Phase 3 RFS and DMFS Endpoints in Resected Melanoma
FDA Grants HDE Approval to OncoSil for Distal Cholangiocarcinoma
FDA Lists More Than 1,500 AI-Enabled Medical Devices as Oncology Applications Expand
ENZAMET: Enzalutamide Maintains Long-Term Survival Benefit in mHSPC
oncoHUB and OncoDaily Announce Strategic Partnership to Strengthen Ukrainian Oncology
Human Connection in Cancer Care with Dr. Aleksandra Filipovic - CancerWorld
Simplify Your ESO College Enrolment With Our New 3-Year Plan - ESO
Bridging the Care Gap: Expanding Humanitarian Access to CLL Treatment Across LMICs
The ESMO Deep Dive: Genitourinary Cancers: Metastatic Castration-Resistant Prostate Cancer 2026 is a virtual webinar scheduled for July 1, 2026, at 18:30 CEST. Chaired by Aurelius Gabriel Omlin, the session focuses on advanced management strategies for mCRPC, including treatment sequencing, the potential role of immunotherapy, and the optimization of patient selection for radioligand therapy. The […]
The ESMO Preceptorship on Endometrial Cancer 2026 is a specialized educational course scheduled for July 1–2, 2026, in Lugano, Switzerland. This intensive program is designed to provide medical oncologists with a comprehensive understanding of the multidisciplinary management of endometrial cancer, from diagnosis and pathology to advanced therapeutic strategies. Key learning objectives typically include exploring the […]
The ESMO Gastrointestinal Cancers Congress 2026 will be held from 1 to 4 July in Munich, Germany, and online. This major event brings together global experts, researchers, and healthcare professionals focused on improving prevention, diagnosis, and treatment across the full spectrum of gastrointestinal cancers. With a programme featuring expert-led discussions, tumour boards, clinical debates, and […]
The ESMO Preceptorship on Endocrine Tumours 2026: Lugano is scheduled for July 8–9, 2026, in Lugano, Switzerland. Co-chaired by Alfredo Berruti and Rocio Garcia-Carbonero, this intensive educational course is designed to provide medical oncologists with a comprehensive understanding of the multidisciplinary management of endocrine neoplasms. The curriculum typically focuses on the latest standards of care, […]
ESMO Preceptorship on Breast Cancer 2026 will take place from 10 Jul 2026 to 11 Jul 2026 in Munich, Germany, under the leadership of Co-Chairs Nadia Harbeck (Munich, Germany) and Peter Schmid (United Kingdom). The program is designed to enable the interdisciplinary discussion and collaboration in the care of patients with breast cancer, to understand […]
The ESMO Course in Medical Oncology for Medical Students 2026 is an interactive, four-day residential educational program taking place from July 24 to 28, 2026, in Valencia, Spain. Organized by the European Society for Medical Oncology (ESMO), the course is specifically designed for fourth and fifth-year medical students. Co-Chaired by Andrés Cervantes and Rodrigo Sanchez […]
The ESMO Guidelines: Real World Cases – Rectal Cancer 2026 webinar, organized by the European Society for Medical Oncology (ESMO), will take place on 29 July 2026 at 18:30 CEST. The session will use a real-world case to explore current ESMO recommendations for rectal cancer, including multimodality treatment, total neoadjuvant therapy, organ preservation, surgical strategies, […]
The ESMO Academy 2026, organized by the European Society for Medical Oncology (ESMO), will take place virtually from 3 August to 12 October 2026. The programme will combine on-demand educational modules with live interactive sessions led by ESMO faculty, covering major tumour types, clinical trial methodology, treatment principles, pharmacokinetics, drug interactions, and topics relevant to […]
The ESMO Deep Dive: First-Line Therapy for HRD-Negative Advanced Ovarian Cancer 2026 webinar, organized by the European Society for Medical Oncology (ESMO), will take place live on 2 September 2026 at 18:30 CEST. The session will examine the reliability of current HRD testing, the role of PARP inhibitors in maintenance therapy, and the emerging potential […]
The Molecular Analysis for Precision Oncology (MAP) Congress 2026, co-organized by the European Society for Medical Oncology (ESMO), Cancer Research UK (CRUK), and Unicancer, is scheduled for 10–11 September 2026 in London, United Kingdom. This high-level, two-day meeting will serve as a platform for experts in oncology, molecular diagnostics, and precision medicine to converge and […]
The ESMO Preceptorship on Tumour-agnostic and Cancer of Unknown Primary 2026 is scheduled to take place in Zurich, Switzerland, from September 18–19, 2026. Chaired by Natalie Cook and Benedikt Westphalen, this educational course aims to provide oncologists with a comprehensive understanding of the management of these complex diseases, from diagnosis to treatment, according to current […]
The ESO Master in Sarcoma is a 15-month academic programme developed by the European School of Oncology in collaboration with the Università Campus Bio-Medico di Roma, designed to advance the clinical and scientific expertise of professionals working in sarcoma management. Awarding 60 ECTS credits upon completion, the programme combines 10 online modules, two in-person seminars, […]
The ESMO Preceptorship on Supportive Care Needs and Cachexia Management in Cancer Patients 2026, organized by the European Society for Medical Oncology (ESMO), will take place on 29–30 September 2026 in Lugano, Switzerland. The course will focus on managing cancer-related symptoms, cachexia, nutritional needs, treatment toxicities, palliative care, end-of-life preparation, and communication with patients and […]
The ESMO Guidelines: Real World Cases - Webinar Series: Uveal Melanoma 2026 is scheduled for Wednesday, September 30, 2026, starting at 18:30 CEST. As uveal melanoma remains a rare and biologically distinct entity from cutaneous melanoma, this webinar provides a critical platform for presenting evidence-based recommendations from the ESMO Clinical Practice Guidelines through the lens […]
The ESMO Advanced Course on Precision Treatment Sequencing in Metastatic Breast Cancer 2026, organized by the European Society for Medical Oncology (ESMO), will take place on 2–3 October 2026 in Singapore. The course will focus on treatment sequencing, the biology of metastatic breast cancer, targeted therapy safety and adverse-event management, and multidisciplinary approaches to improving […]
The ESMO Advanced Course on Optimising Treatment Sequencing in Advanced NSCLC 2026, oorganized by the European Society for Medical Oncology (ESMO), will take place on 2–3 October 2026 in Singapore. The course will focus on sequencing strategies for actionable genomic alteration-positive NSCLC, biomarker-driven treatment using NGS, immunohistochemistry, and liquid biopsy, and emerging therapies such as […]
